Neurology
Supraclavicular Brachial Plexus Block
0
Pipeline Programs↗
3
Active Trials↗
0
Companies Involved↗
Supraclavicular Brachial Plexus Block is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
26
clinical trials
Completed18 · 69%
Unknown status4 · 15%
Not yet recruiting2 · 8%
Terminated1 · 4%
Recruiting1 · 4%
Clinical Trials
Trial Activity
26 trials
Perineural Dexamethasone, Dexmedetomidine, or Their Combination to Reduces Rebound Pain After Supraclavicular Brachial Plexus Block
Not yet recruiting·—·Phase 4·NCT07299877·75 enrolled
Early Detection of Supraclavicular Brachial Plexus Block Failure Using Infrared Thermography and Perfusion Index
Not yet recruiting·—·N/A·NCT07092891·80 enrolled
Peri-neural Dexmedetomidine Versus Dexamethasone for Supraaclavicular Block Adjuvant to Bupivacaine Supraclavicular Brachial Plexus Block
Completed·—·N/A·NCT04694105·42 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)